Death Watch I: Cytotoxicity Detection

Suppliers of Cytotoxicity Reagents (Part 1) Suppliers of Cytotoxicity Reagents (Part 2) Editor's note: This is the first in a two-part series on cell death. A second article on apoptosis will be published June 25. Courtesy of Loats AssociatesA comet assay showing degradation of 45 percent of the genomic DNA A few years ago the ultimate fate of dead cells was the laboratory trashcan. But cell necrobiology (the study of mechanisms of cell death) is now one of the hot fields of science.1 Cells c

Written byJorge Cortese
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Suppliers of Cytotoxicity Reagents (Part 1)

Suppliers of Cytotoxicity Reagents (Part 2)

Editor's note: This is the first in a two-part series on cell death. A second article on apoptosis will be published June 25.

Courtesy of Loats AssociatesA comet assay showing degradation of 45 percent of the genomic DNA A few years ago the ultimate fate of dead cells was the laboratory trashcan. But cell necrobiology (the study of mechanisms of cell death) is now one of the hot fields of science.1 Cells can die either passively (necrosis), or by an active mechanism involving signal transduction cascades (apoptosis). The degradative process of necrosis is accompanied by mitochondrial swelling and plasma membrane permeation; apoptosis is accompanied by an articulated breakdown of the cell into membrane-bound particles termed apoptotic bodies. In some cases cytotoxic effects and processes are typically apoptotic; the selection of T-lymphocytes and the effects of natural killer (NK) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies